PK
Priyanka Kumari
About Priyanka Kumari
Data last updated:
Priyanka Kumari is an Additional Director at Apex Institute Of Medical Science Private Limited (since 2024). The companies operate in Healthcare. Apex Institute Of Medical Science Private Limited reported revenue of ₹37.9 Lakh (FY 2025). Earlier, Priyanka Kumari was a Director at Apex Nursing Home Private Limited (from 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 21 May 2024 | 2010 | ₹37.9 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Jul 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Priyanka Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pintu Kumar Sinha | 06426873 | Apex Institute Of Medical Science Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Priyanka Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priyanka Kumari
Priyanka Kumari currently holds 1 directorship: Apex Institute Of Medical Science Private Limited (Additional Director, since 21 May 2024, revenue ₹37.9 Lakh (FY 2025)).
Priyanka Kumari was first appointed on 04 Jul 2017 as Director at Apex Nursing Home Private Limited. The most recent appointment on record is 21 May 2024 at Apex Institute Of Medical Science Private Limited.
Priyanka Kumari held 1 earlier board appointment: Apex Nursing Home Private Limited (Director, from 04 Jul 2017).
The current boards of Priyanka Kumari's companies include Pintu Kumar Sinha (Apex Institute Of Medical Science Private Limited).